The expression of IL-23 (IL-23+) in a DC, along with the higher expression of phenotype maturation ligands, represents pro-tumorigenic phenotype which is involved in cancer progression and immune-suppression as compared to IL-23 negative (IL-23-) phenotype [24]. This evidence concerns the gene IL37 and cancer.